BioCentury | Jan 31, 2020
Distillery Therapeutics
Supplementation with for alcoholic fatty liver disease
...liver disease. TARGET/MARKER/PATHWAY: Not applicable EXPERIMENTAL SYSTEM: Patient samples; mice LICENSING STATUS: Patented; licensed to KoBioLabs Inc....
...published online Dec. 19. 2019 doi:10.1016/j.chom.2019.11.001 CONTACT: GwangPyo Ko, Seoul National University, Seoul, South Korea; KoBioLabs Inc....
...published online Dec. 19. 2019 doi:10.1016/j.chom.2019.11.001 CONTACT: GwangPyo Ko, Seoul National University, Seoul, South Korea; KoBioLabs Inc....
